|
つくばリポジトリ (Tulips-R) >
0 コンテンツタイプ別 (Content type) >
01 雑誌発表論文等 (Journal article, etc.) >
Medical oncology >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/2241/106532
|
| Title: | Interstitial lung disease in patients with small cell lung cancer |
| Authors: | Miyazaki, Kunihiko
Satoh, Hiroaki
Kurishima, Koichi
Nakamura, Ryota
Ishikawa, Hiroichi
Kagohashi, Katsunori
Nobuyuki, Hizawa
佐藤, 浩昭
栗島, 浩一
籠橋, 克紀
檜澤, 伸之 |
| Issue Date: | Sep-2010 |
| Publisher: | Humana Press |
| Journal Title: | Medical oncology |
| Volume: | 27 |
| Issue: | 32 |
| Start Page: | 763 |
| End Page: | 767 |
| DOI: | 10.1007/s12032-009-9283-z |
| PMID: | 19657749 |
| Abstract: | Interstitial lung disease (ILD) and lung cancer are two of the most common respiratory diseases. The aim of this study was to demonstrate the prognostic significance of the presence of ILD in patients with small cell lung cancer (SCLC). All the patients with SCLC who were admitted to our hospitals over a 23-year period up to 2008 were retrospectively analyzed. During the study period, 332 SCLC patients were consecutively admitted to our hospitals. Among them, 15 (4.5%) were diagnosed as having both SCLC and ILD. In univariate and multivariate analysis, female sex, early stage, good performance status, and chemotherapy were favorable prognostic factors. The presence of ILD was confirmed as an unfavorable prognostic factor. Existing ILD adversely affects the outcome of SCLC. When deciding whether to offer a standard therapy that may increase treatment-related mortality, the patient’s medical condition, including ILD, should be taken into consideration. |
| URI: | http://hdl.handle.net/2241/106532 |
| Rights: | ©Humana Press Inc. 2009 |
| Text Version: | author |
| Appears in Collections: | 籠橋 克紀（Kagohashi Katsunori）
檜澤 伸之 (Hizawa Nobuyuki)
栗島 浩一 (Kurishima Koichi)
佐藤 浩昭 (Satoh Hiroaki)
Medical oncology
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|
